1
|
Fraudet B, Leblong E, Piette P, Nicolas B, Gouranton V, Babel M, Devigne L, Pasteau F, Gallien P. Evaluation of power wheelchair driving performance in simulator compared to driving in real-life situations: the SIMADAPT (simulator ADAPT) project-a pilot study. J Neuroeng Rehabil 2024; 21:60. [PMID: 38654367 PMCID: PMC11036562 DOI: 10.1186/s12984-024-01354-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Accepted: 04/03/2024] [Indexed: 04/25/2024] Open
Abstract
OBJECTIVE The objective of this study was to evaluate users' driving performances with a Power Wheelchair (PWC) driving simulator in comparison to the same driving task in real conditions with a standard power wheelchair. METHODS Three driving circuits of progressive difficulty levels (C1, C2, C3) that were elaborated to assess the driving performances with PWC in indoor situations, were used in this study. These circuits have been modeled in a 3D Virtual Environment to replicate the three driving task scenarios in Virtual Reality (VR). Users were asked to complete the three circuits with respect to two testing conditions during three successive sessions, i.e. in VR and on a real circuit (R). During each session, users completed the two conditions. Driving performances were evaluated using the number of collisions and time to complete the circuit. In addition, driving ability by Wheelchair Skill Test (WST) and mental load were assessed in both conditions. Cybersickness, user satisfaction and sense of presence were measured in VR. The conditions R and VR were randomized. RESULTS Thirty-one participants with neurological disorders and expert wheelchair drivers were included in the study. The driving performances between VR and R conditions were statistically different for the C3 circuit but were not statistically different for the two easiest circuits C1 and C2. The results of the WST was not statistically different in C1, C2 and C3. The mental load was higher in VR than in R condition. The general sense of presence was reported as acceptable (mean value of 4.6 out of 6) for all the participants, and the cybersickness was reported as acceptable (SSQ mean value of 4.25 on the three circuits in VR condition). CONCLUSION Driving performances were statistically different in the most complicated circuit C3 with an increased number of collisions in VR, but were not statistically different for the two easiest circuits C1 and C2 in R and VR conditions. In addition, there were no significant adverse effects such as cybersickness. The results show the value of the simulator for driving training applications. Still, the mental load was higher in VR than in R condition, thus mitigating the potential for use with people with cognitive disorders. Further studies should be conducted to assess the quality of skill transfer for novice drivers from the simulator to the real world. Trial registration Ethical approval n∘ 2019-A001306-51 from Comité de Protection des Personnes Sud Mediterranée IV. Trial registered the 19/11/2019 on ClinicalTrials.gov in ID: NCT04171973.
Collapse
Affiliation(s)
- Bastien Fraudet
- LAB Saint Hélier, Pôle MPR St Hélier, 54 rue St Hélier, 35043, Rennes Cedex, France.
| | - Emilie Leblong
- LAB Saint Hélier, Pôle MPR St Hélier, 54 rue St Hélier, 35043, Rennes Cedex, France
- INSA Rennes, CNRS, Inria, University of Rennes, Rennes, France
| | - Patrice Piette
- LAB Saint Hélier, Pôle MPR St Hélier, 54 rue St Hélier, 35043, Rennes Cedex, France
| | - Benoit Nicolas
- LAB Saint Hélier, Pôle MPR St Hélier, 54 rue St Hélier, 35043, Rennes Cedex, France
| | | | - Marie Babel
- INSA Rennes, CNRS, Inria, University of Rennes, Rennes, France
| | - Louise Devigne
- CNRS, IRISA, Inria, University of Rennes, Rennes, France
| | | | - Philippe Gallien
- LAB Saint Hélier, Pôle MPR St Hélier, 54 rue St Hélier, 35043, Rennes Cedex, France
| |
Collapse
|
2
|
Fraudet B, Leblong E, Piette P, Nicolas B, Devigne L, Babel M, Pasteau F, Routhier F, Gallien P. SWADAPT2: benefits of a collision avoidance assistance for powered wheelchair users in driving difficulty. Disabil Rehabil Assist Technol 2023:1-9. [PMID: 37681970 DOI: 10.1080/17483107.2023.2253339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/09/2023]
Abstract
PURPOSE In France, tens of thousands of people use a wheelchair. Driving powered wheelchairs (PWCs) present risks for users and their families. The risk of collision in PWC driver increases with severity of disability and may reduce their independence to drive. The European ADAPT project has developed a robotic assistance add-on for PWCs to prevent collisions and improve their driving performance. MATERIALS AND METHODS The aim of the SWADAPT2 study is to assess the benefit of this robotic assistance add-on arranged on a Standard Quickie Salsa M2 PWC in a population of PWC drivers with neurological disorders and driving difficulties. Eighteen (18) participants tested the system on three circuits of increasing difficulty, with and without the robotic assistance add-on. RESULTS The benefit of the robotic assistance add-on was important especially on the more difficult circuits without impacting cognitive load or driving speed. The number of collisions was significantly reduced when using robotic assistance add-on from 2.16 to 0.36 on circuit 2 (p = 0.009) and from 7.3 to 1.33 on circuit 3 (p = 0.0009). Task load demand was not increased with the assistance. CONCLUSION Finally, this system seems to be indicated to assist and improve driving safety for PWC drivers in driving difficulty. Evaluation was performed in controlled environments; therefore, further evaluation in real-world scenarios is needed to reach technology readiness.
Collapse
Affiliation(s)
| | | | | | | | - Louise Devigne
- Institut National des Sciences Appliquées de Rennes - CNRS, Rennes, France
| | - Marie Babel
- Institut National des Sciences Appliquées de Rennes - CNRS, Rennes, France
| | - François Pasteau
- Institut National des Sciences Appliquées de Rennes - CNRS, Rennes, France
| | - François Routhier
- Department of Rehabilitation, Université Laval, Québec, Canada
- Centre for interdisciplinary research in rehabilitation and social integration, Centre intégré universitaire de santé et services de sociaux de la Capitale-Nationale, Québec, Canada
| | | |
Collapse
|
3
|
Roy AL, Duruflé A, Piette P, Fraudet B, Lofficial V, Gallien P. Telerehabilitation during the COVID-19 pandemic, what are the determinants of satisfaction for chronic diseases? a retrospective study. Front Rehabil Sci 2023; 4:1108087. [PMID: 36776736 PMCID: PMC9909006 DOI: 10.3389/fresc.2023.1108087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/25/2022] [Accepted: 01/09/2023] [Indexed: 01/27/2023]
Abstract
Background During the Covid-19 health crisis, telerehabilitation provided a solution to ensure the continuity of care. Since then, it has been offered as an alternative to face-to-face rehabilitation in chronic conditions. Data measuring satisfaction are essential to adapt and increase the effectiveness of this type of programme. Aim and scope This research focused on determining the most significant determinants of participant satisfaction in a telerehabilitation programme. Methods We conducted a retrospective study by analysing the satisfaction questionnaire used from the start of the programme. Result Two hundred and ten (210) participants completed the programme; 180 questionnaires were filled in and 175 analyzed of which 70 with chronic low back pain (CLBP), 59 for multiple sclerosis (MS) and 22 with parkinson's disease (PD). Satisfaction was high for all participants (scoring out of 10, mean = 8.22 sd = 1.53), but the determinants reported for the three main conditions involved in the programme differed. Main determinant was "benefice" for CLBP (p = 1.23e-05), "home exercises adapted" for MS (p = 0.000679) and "interest in staying at home" for PD (p = 1.84e-05). Conclusion Depending on the context of the condition/disease, the drivers of satisfaction were not identical. Knowledge of these determinants will allow us to further improve the programme. However, some unresolved questions remain regarding the place of therapists, their role and the skills required for a successful telerehabilitation programme. Further studies are required to understand the impact.
Collapse
|
4
|
Duruflé A, Le Meur C, Piette P, Fraudet B, Leblong E, Gallien P. Cost effectiveness of a telerehabilitation intervention vs home based care for adults with severe neurologic disability: A randomized clinical trial. Digit Health 2023; 9:20552076231191001. [PMID: 37545632 PMCID: PMC10403989 DOI: 10.1177/20552076231191001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Accepted: 07/13/2023] [Indexed: 08/08/2023] Open
Abstract
Context Several options are available for the care of neurological conditions including care delivered in rehabilitation centres, at home or remotely. While economic studies are available comparing centres and homes, very little economic data relates to mobile teams comparing face-to-face and remote care. Objective To conduct an economic study comparing face-to-face care at home and care delivered remotely (tele-rehabilitation). Method A randomised clinical study with two groups; a control group receiving home care and an experimental group receiving tele-rehabilitation. The primary outcome measure was the ICER (Incremental Cost Effectiveness Ratio). Participants Patients with severe neurological disabilities. Results 80 patients were enrolled in the study; 77 were analysed to calculate the ICER, which was positive and located in the SW quadrant. A bootstrap with 1000 replications was positioned at 72.8% in the SW quadrant. Conclusion Tele-rehabilitation is an acceptable alternative to the management of neurological patients at home. In the mildest cases, remote-rehabilitation may even be dominant. More extensive studies are needed to specify the indications.
Collapse
Affiliation(s)
| | - Claire Le Meur
- Rehabilitation Center, Pôle Saint Helier, Rennes, France
| | - Patrice Piette
- Rehabilitation Center, Pôle Saint Helier, Rennes, France
| | | | - Emilie Leblong
- Rehabilitation Center, Pôle Saint Helier, Rennes, France
| | | |
Collapse
|
5
|
Blanc M, Roy AL, Fraudet B, Piette P, Le Toullec E, Nicolas B, Gallien P, Leblong E. Evaluation of a Digitally Guided Self-Rehabilitation Device Coupled With Telerehabilitation Monitoring in Patients With Parkinson Disease (TELEP@RK): Open, Prospective Observational Study. JMIR Serious Games 2022; 10:e24946. [PMID: 35129449 PMCID: PMC8861867 DOI: 10.2196/24946] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2020] [Revised: 05/13/2021] [Accepted: 05/29/2021] [Indexed: 12/03/2022] Open
Abstract
Background Parkinson disease is a neurodegenerative disease causing a progressive loss of autonomy. This requires long-term rehabilitation care. Currently, new technologies are being developed for use in daily life, and there is a progressive implementation of telerehabilitation. Objective The aim of this study (the TELEP@RK study) is to evaluate the uses of a digital self-rehabilitation device in patients with Parkinson disease and their independent physiotherapists on the scale of a health territory. Methods A total of 10 independent physiotherapists and 31 patients with Parkinson disease were followed for 1 year to evaluate the use of a telerehabilitation tool (digital tablet and inertial sensor) via questionnaires of the Unified Theory of Acceptance and Use of Technology (UTAUT). The questionnaires were submitted to participants at 0, 2, and 12 months from the start of follow-up. The averages of the scores of the different determinants and constructs of the UTAUT questionnaires were compared at the different follow-up times. Results Among professionals, the averages of the various determinants were generally high at the beginning of the study with an average (out of 5) performance expectancy of 4.19, effort expectancy of 3.88, social influence of 3.95, facilitating conditions of 4, and intention to use of 3.97. These averages decreased over time. Conclusions Acceptability, acceptance, and appropriation of the tool were very high among the physiotherapists as well as the patients, despite the tool’s lack of evolution during the study. In the current health care context, these results allow us to envision a new organization of the care pathway for patients with chronic diseases, with the increased use of new technologies associated with telecare.
Collapse
Affiliation(s)
- Margaux Blanc
- University Hospital Center (CHU) Rennes, University of Rennes, Rennes, France.,Hospital Center (CH) Saint Malo, Saint Malo, France
| | - Anne-Laure Roy
- Physical and Rehabilitation Medicine (MPR) Pole Saint Helier, Rennes, France
| | - Bastien Fraudet
- Physical and Rehabilitation Medicine (MPR) Pole Saint Helier, Rennes, France
| | - Patrice Piette
- Physical and Rehabilitation Medicine (MPR) Pole Saint Helier, Rennes, France
| | - Elodie Le Toullec
- Physical and Rehabilitation Medicine (MPR) Pole Saint Helier, Rennes, France
| | - Benoit Nicolas
- Physical and Rehabilitation Medicine (MPR) Pole Saint Helier, Rennes, France
| | - Philippe Gallien
- Physical and Rehabilitation Medicine (MPR) Pole Saint Helier, Rennes, France
| | - Emilie Leblong
- Physical and Rehabilitation Medicine (MPR) Pole Saint Helier, Rennes, France
| |
Collapse
|
6
|
Veillard D, Deburghgraeve V, Le Page E, Debouverie M, Wiertlewski S, Gallien P, Edan G. Developing tools to evaluate quality of care management for patients living with multiple sclerosis: An original French initiative. Rev Neurol (Paris) 2022; 178:722-731. [DOI: 10.1016/j.neurol.2021.12.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2021] [Revised: 11/15/2021] [Accepted: 12/13/2021] [Indexed: 11/28/2022]
|
7
|
Veillard D, Le Page E, Epstein J, Wiertlewski S, Gallien P, Hamonic S, Debouverie M, Edan G. Evaluation of the quality of the care pathway for patients with multiple sclerosis in France: Results of an original study of a cohort of 700 patients. Rev Neurol (Paris) 2021; 178:580-590. [PMID: 34893353 DOI: 10.1016/j.neurol.2021.09.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Revised: 09/17/2021] [Accepted: 09/24/2021] [Indexed: 12/16/2022]
Abstract
INTRODUCTION Evaluating the quality of the care pathway for patients with chronic diseases, such as multiple sclerosis (MS), is an important issue. Process indicators are a recognized method for evaluating professional practices. However, these tools have been little developed in the field of MS, and few data are available. The aim of this study was to describe, retrospectively, with validated indicators, the quality of the care pathway in a population-based cohort of 700 patients with the first manifestations of the disease occurring between January 1, 2000 and December 31, 2001 and during the first 10 years of disease. METHOD This assessment was based on 48 indicators specific to MS. The information required for the calculation of each indicator was collected from the source files of the 700 patients of the cohort. RESULTS Data for the 10 years of follow-up were collected for 80% of the patients. In total, 36 indicators were calculated. These results reveal that there is room for improvement, particularly in terms of the initial assessment, access to ophthalmological evaluation, employment, obtaining an evaluation of the need for rehabilitation and access to such care. CONCLUSION The results of this survey provide access to unprecedented new data in France, that professionals and patients can appropriate to improve the targeting of actions, to improve the quality of care further for patients with MS in France. We propose to continue this process by submitting, for discussion, a targeted list of updated indicators relating to changes in guidelines, and in issues concerning the quality of patient management.
Collapse
Affiliation(s)
- D Veillard
- Service d'épidémiologie et de santé publique, CHU, 35000 Rennes, France; Équipe d'accueil 3279, centre d'études et de recherche sur les services de santé, Aix-Marseille Université, 13000 Marseille, France.
| | - E Le Page
- Inserm, service de neurologie, Clinical Neuroscience Center CIC-P 1414, CHU, 35000 Rennes, France.
| | - J Epstein
- Service d'épidémiologie, clinique du centre hospitalier universitaire and Clinical Investigation Center CIC 1433, 54000 Nancy, France.
| | - S Wiertlewski
- Clinique neurologique, CHU de Nantes, 44000 Nantes, France.
| | - P Gallien
- Pôle de médecine physique et de rehabilitation Saint-Hélier, 35000 Rennes, France.
| | - S Hamonic
- Service d'épidémiologie et de santé publique, CHU, 35000 Rennes, France.
| | - M Debouverie
- Équipe d'accueil 4360 adaptation, mesure et évaluation en santé, approches interdisciplinaires, service de neurologie, université de Lorraine, CHU de Nancy, 54000 Nancy, France.
| | - G Edan
- Inserm, Clinical Neuroscience Centre, CIC-P 1414, Université de Rennes 1, 35000 Rennes, France.
| |
Collapse
|
8
|
Esquenazi A, Feng W, Wittenberg G, Gallien P, Baricich A, Fanning K, Zuzek A, Francisco G, Bandari D. Consistent Dosing Over Time And Within Treatment Interval Groups With Onabotulinumtoxina: Analysis from the Adult Spasticity International Registry (ASPIRE). Arch Phys Med Rehabil 2021. [DOI: 10.1016/j.apmr.2021.07.605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
9
|
Leblong E, Fraudet B, Devigne L, Babel M, Pasteau F, Nicolas B, Gallien P. SWADAPT1: assessment of an electric wheelchair-driving robotic module in standardized circuits: a prospective, controlled repeated measure design pilot study. J Neuroeng Rehabil 2021; 18:140. [PMID: 34530839 PMCID: PMC8447623 DOI: 10.1186/s12984-021-00923-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Accepted: 08/23/2021] [Indexed: 11/30/2022] Open
Abstract
Objectives The objective of this study is to highlight the effect of a robotic driver assistance module of powered wheelchair (PWC), using infrared sensors and accessorizing a commercial wheelchair) on the reduction of the number of collisions in standardized circuit in a population with neurological disorders by comparing driving performance with and without assistance. Methods This is a prospective, single-center, controlled, repeated measure design, single-blind pilot study including patients with neurological disabilities who are usual drivers of electric wheelchairs. The main criterion for evaluating the device is the number of collisions with and without the assistance of a prototype anti-collision system on three circuits of increasing complexity. Travel times, cognitive load, driving performance, and user satisfaction are also analyzed. Results 23 Patients, 11 women and 12 men with a mean age of 48 years old completed the study. There was a statistically significant reduction in the number of collisions on the most complex circuit: 61% experienced collisions without assistance versus 39% with assistance (p = 0.038). Conclusion This study concludes that the PWC driving assistance module is efficient in terms of safety without reducing the speed of movement in a population of people with disabilities who are habitual wheelchair drivers. The prospects are therefore to conduct tests on a target population with driving failure or difficulty who could benefit from this device so as to allow them to travel independently and safely.
Collapse
Affiliation(s)
- Emilie Leblong
- Pôle MPR St Hélier, 54 Rue St Hélier, 35043, Rennes Cedex, France
| | - Bastien Fraudet
- Pôle MPR St Hélier, 54 Rue St Hélier, 35043, Rennes Cedex, France. .,Living Lab ISAR, 54 Rue St Hélier, 35043, Rennes Cedex, France.
| | - Louise Devigne
- Institut National des Sciences Appliquées de Rennes-CNRS, Inria, Irisa-UMR6074, Rennes, France
| | - Marie Babel
- Institut National des Sciences Appliquées de Rennes-CNRS, Inria, Irisa-UMR6074, Rennes, France
| | - François Pasteau
- Institut National des Sciences Appliquées de Rennes-CNRS, Inria, Irisa-UMR6074, Rennes, France
| | - Benoit Nicolas
- Pôle MPR St Hélier, 54 Rue St Hélier, 35043, Rennes Cedex, France
| | - Philippe Gallien
- Pôle MPR St Hélier, 54 Rue St Hélier, 35043, Rennes Cedex, France
| |
Collapse
|
10
|
Tanoh IC, Maillart E, Labauge P, Cohen M, Maarouf A, Vukusic S, Donzé C, Gallien P, De Sèze J, Bourre B, Moreau T, Louapre C, Vallée M, Bieuvelet S, Klaeylé L, Argoud AL, Zinaï S, Tourbah A. MSCopilot: New smartphone-based digital biomarkers correlate with Expanded Disability Status Scale scores in people with Multiple Sclerosis. Mult Scler Relat Disord 2021; 55:103164. [PMID: 34352512 DOI: 10.1016/j.msard.2021.103164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Revised: 06/30/2021] [Accepted: 07/21/2021] [Indexed: 10/20/2022]
Abstract
BACKGROUND A previous clinical study showed the high specificity, sensitivity and reliability of MSCopilot, a software medical device designed by Ad Scientiam for the self-assessment of people with Multiple Sclerosis (PwMS), compared to the traditional Multiple Sclerosis Functional Composite (MSFC). We conducted further analyses to assess MSCopilot's performance with respect to the Expanded Disability Status Scale (EDSS). METHODS The data of 116 PwMS were analysed. We studied the correlations between MSCopilot scores and the EDSS, and their ability to distinguish PwMS with high and low EDSS through a study of the distribution of the digital test scores as well as logistic regression models. The same analyses were performed using the MSFC tests. RESULTS MSCopilot composite scores were as highly correlated to the EDSS (|r| = 0.65, p < 0.01) as their MSFC counterparts, confirming the known correlation of the MSFC with the EDSS. In a linear regression framework, the Walking digital tests have good explanatory power, especially for PwMS with EDSS > 3.5 (R²adj=0.47). The mean values of each MSCopilot subscore were significantly different between patients with an EDSS > 3.5 and others (p < 0.05), which could not be proved for the MSFC Cognition tests. MSCopilot4 was the best model to predict an EDSS score > 3.5 (AUC = 0.92). CONCLUSION These analyses confirm the reliability of MSCopilot and show interesting correlations with the EDSS (similar results obtained with the MSFC). MSCopilot was able to highlight nuances in the different stages of MS the MSFC could not capture.
Collapse
Affiliation(s)
| | | | - Pierre Labauge
- Department of Neurology, Montpellier University Hospital, Montpellier, France
| | - Mikael Cohen
- Department of Neurology, Nice University Hospital, Nice, France
| | - Adil Maarouf
- CNRS, CRMBM, APHM, Aix-Marseille University, Marseille; Pôle de Neurosciences Cliniques, Marseille, France
| | - Sandra Vukusic
- Department of Neurology, Hospices Civils de Lyon, Bron, France; INSERM 1028 et CNRS UMR 5292, University Lyon 1, Lyon, France
| | - Cécile Donzé
- Department of Physical and Rehabilitation Medicine, Groupe Hospitalier de l'Institut Catholique de Lille, Lille, France
| | - Philippe Gallien
- Physical Rehabilitation Medicine, Pôle Saint Helier, Rennes, France
| | - Jérôme De Sèze
- Department of Neurology, Hôpital Civil, Strasbourg University, Strasbourg, France
| | - Bertrand Bourre
- Department of Neurology, Rouen University Hospital, Rouen, France
| | - Thibault Moreau
- Department of Neurology, Dijon University Hospital, Dijon, France
| | - Céline Louapre
- Department of Neurology, Pitié-Salpêtrière Hospital Paris, France
| | - Morgane Vallée
- Ad Scientiam, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, Paris, France
| | - Séverine Bieuvelet
- Ad Scientiam, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, Paris, France
| | - Lissandra Klaeylé
- Ad Scientiam, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, Paris, France
| | - Anne-Laure Argoud
- Ad Scientiam, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, Paris, France
| | - Saad Zinaï
- Ad Scientiam, Paris Brain Institute (ICM), Pitié-Salpêtrière Hospital, Paris, France
| | - Ayman Tourbah
- Service de Neurologie, Hôpital Raymond Poincaré, Garches, UFR Simone Veil, UVSQ, INSERM U 1195, APHP, Université Paris Saclay, France
| |
Collapse
|
11
|
Esquenazi A, Francisco GE, Feng W, Baricich A, Gallien P, Fanning K, Zuzek A, Bandari DS, Wittenberg GF. Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study. Arch Phys Med Rehabil 2021; 102:2172-2184.e6. [PMID: 34245684 DOI: 10.1016/j.apmr.2021.06.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2021] [Revised: 05/19/2021] [Accepted: 06/18/2021] [Indexed: 10/20/2022]
Abstract
OBJECTIVE To identify baseline characteristics and treatment-related variables that affect adherence to onabotulinumtoxinA treatment from the Adult Spasticity International Registry (ASPIRE) study. DESIGN Prospective, observational registry (NCT01930786). SETTING International clinical sites. PARTICIPANTS Adults with spasticity (N=730). INTERVENTIONS OnabotulinumtoxinA at clinician's discretion. MAIN OUTCOME MEASURES Clinically meaningful thresholds used for treatment adherent (≥3 treatment sessions during 2-year study) and nonadherent (≤2 sessions). Data analyzed using logistic regression and presented as odds ratios (ORs) with 95% confidence intervals (CIs). Treatment-related variables assessed at sessions 1 and 2 only. RESULTS Of the total population, 523 patients (71.6%) were treatment adherent with 5.3±1.6 sessions and 207 (28.4%) were nonadherent with 1.5±0.5 sessions. In the final model (n=626/730), 522 patients (83.4%) were treatment adherent and 104 (16.6%) were nonadherent. Baseline characteristics associated with adherence: treated in Europe (OR=1.84; CI, 1.06-3.21; P=.030) and use of orthotics (OR=1.88; CI, 1.15-3.08; P=.012). Baseline characteristics associated with nonadherence: history of diplopia (OR=0.28; CI, 0.09-0.89; P=.031) and use of assistive devices (OR=0.51; CI, 0.29-0.90; P=.021). Treatment-related variables associated with nonadherence: treatment interval ≥15 weeks (OR=0.43; CI, 0.26-0.72; P=.001) and clinician dissatisfaction with onabotulinumtoxinA to manage pain (OR=0.18; CI, 0.05-0.69; P=.012). Of the population with stroke (n=411), 288 patients (70.1%) were treatment adherent with 5.3±1.6 sessions and 123 (29.9%) were nonadherent with 1.5±0.5 session. In the final stroke model (n=346/411), 288 patients (83.2%) were treatment adherent and 58 (16.8%) were nonadherent. Baseline characteristics associated with adherence: treated in Europe (OR=2.99; CI, 1.39-6.44; P=.005) and use of orthotics (OR=3.18; CI, 1.57-6.45; P=.001). Treatment-related variables associated with nonadherence: treatment interval ≥15 weeks (OR=0.42; CI, 0.21-0.83; P=.013) and moderate/severe disability on upper limb Disability Assessment Scale pain subscale (OR=0.40; CI, 0.19-0.83; P=.015). CONCLUSIONS These ASPIRE analyses demonstrate real-world patient and clinical variables that affect adherence to onabotulinumtoxinA and provide insights to help optimize management strategies to improve patient care.
Collapse
Affiliation(s)
| | - Gerard E Francisco
- University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX
| | - Wuwei Feng
- Department of Neurology, Duke University School of Medicine, Durham, NC
| | - Alessio Baricich
- Physical and Rehabilitation Medicine, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy
| | - Philippe Gallien
- Physical Medicine and Rehabilitation, Pôle MPR Saint Hélier, Rennes, France
| | | | - Aleksej Zuzek
- Medical Affairs, Spasticity and Movement Disorders/Urology, Allergan, an AbbVie Company, Irvine, CA
| | | | | |
Collapse
|
12
|
Esquenazi A, Feng W, Wittenberg G, Gallien P, Baricich A, Fanning K, Zuzek A, Francisco G, Bandari D. Adherence to OnabotulinumtoxinA Treatment in Post-Stroke and Multiple Sclerosis Patients with Spasticity from the ASPIRE Study. Arch Phys Med Rehabil 2020. [DOI: 10.1016/j.apmr.2020.09.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
13
|
Picot D, Gallien P, Duruflé A, Guillou F, Achille-Fauveau S, Colin A, Fraudet B, Nicolas B. La Libre pesée : pour que les personnes en fauteuil roulant connaissent et surveillent leur poids. NUTR CLIN METAB 2020. [DOI: 10.1016/j.nupar.2020.02.251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
14
|
Wissel J, Fheodoroff K, Hoonhorst M, Müngersdorf M, Gallien P, Meier N, Hamacher J, Hefter H, Maisonobe P, Koch M. Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment. Front Neurol 2020; 11:104. [PMID: 32184753 PMCID: PMC7058702 DOI: 10.3389/fneur.2020.00104] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2019] [Accepted: 01/30/2020] [Indexed: 11/13/2022] Open
Abstract
Background: Recent studies of botulinum toxin for post-stroke spasticity indicate potential benefits of early treatment (i. e., first 6 months) in terms of developing hypertonicity, pain and passive function limitations. This non-interventional, longitudinal study aimed to assess the impact of disease duration on the effectiveness of abobotulinumtoxinA treatment for upper limb spasticity. Methods: The early-BIRD study (NCT01840475) was conducted between February 2013 and 2018 in 43 centers across Germany, France, Austria, Netherlands and Switzerland. Adult patients with post-stroke upper limb spasticity undergoing routine abobotulinumtoxinA treatment were followed for up to four treatment cycles. Patients were categorized by time from stroke event to first botulinum toxin-A treatment in the study (as defined by the 1st and 3rd quartiles time distribution) into early-, medium- and late- start groups. We hypothesized that the early-start group would show a larger benefit (decrease) as assessed by the modified Ashworth scale (MAS, primary endpoint) on elbow plus wrist flexors compared with the late-start group. Results: Of the 303 patients enrolled, 292 (96.4%) received ≥1 treatment and 186 (61.4%) received 4 injection cycles and completed the study. Patients in all groups showed a reduction in MAS scores from baseline over the consecutive injection visits (i.e., at end of each cycle). Although reductions in MAS scores descriptively favored the early treatment group, the difference compared to the late group did not reach statistical significance at the last study visit (ANCOVA: difference in adjusted means of 0.15, p = 0.546). Conclusions: In this observational, routine-practice study, patients in all groups displayed a benefit from abobotulinumtoxinA treatment, supporting the effectiveness of treatment for patients at various disease stages. Although the data revealed some trends in favor of early vs. late treatment, we did not find strong evidence for a significant benefit of early vs. late start of treatment in terms of reduction in MAS scores.
Collapse
Affiliation(s)
| | | | | | - Martina Müngersdorf
- Neurologisches Zentrum für Bewegungsstörungen und Diagnostik, Berlin, Germany
| | | | - Niklaus Meier
- Department of Neurology, University Hospital Bern and University of Bern, Bern, Switzerland
| | | | - Harald Hefter
- Department of Neurology, University of Düsseldorf, Düsseldorf, Germany
| | | | | |
Collapse
|
15
|
van der Slot WMA, Benner JL, Brunton L, Engel JM, Gallien P, Hilberink SR, Månum G, Morgan P, Opheim A, Riquelme I, Rodby-Bousquet E, Şimşek TT, Thorpe DE, van den Berg-Emons RJG, Vogtle LK, Papageorgiou G, Roebroeck ME. Pain in adults with cerebral palsy: A systematic review and meta-analysis of individual participant data. Ann Phys Rehabil Med 2020; 64:101359. [PMID: 32061920 DOI: 10.1016/j.rehab.2019.12.011] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2019] [Revised: 12/29/2019] [Accepted: 12/31/2019] [Indexed: 12/16/2022]
Abstract
BACKGROUND There is little focus on adults with cerebral palsy (CP) in research and health care and insufficient knowledge on how to identify and manage pain in this population. OBJECTIVES This systematic review and meta-analysis aimed to determine whether pain prevalence in adults with CP is high and to explore variations in pain prevalence of subgroups, pain locations, pain severity and pain interference. METHODS Potential datasets were identified by experts in the field and literature searches in Embase, MEDLINE, and Cochrane, from January 2000 to October 2016. Included studies had a representative sample of ≥25 adults with CP and ≥1 pain outcomes. Methodological quality assessment, pain prevalence estimates and logistic regression models for subgroup effects on pain prevalence were conducted. RESULTS In total, 17 eligible studies were identified from 4584 publications. A meta-analysis was performed with individual participant data from 15 studies totalling 1243 participants (mean [SD] age 34.3 [12.6] years). Overall mean pain prevalence was 70% (95% CI 62-78). Women were more likely to have pain than men (P<0.001). The odds of pain was increased in adults with gross motor function level II (odds ratio [OR] 1.92, 95% CI 1.22-3.12) and IV (OR 1.77, 95% CI 1.03-4.29). Participants with pain reported pain predominantly in the legs (76%, 95% CI 66-84), and mean pain severity was 3.7/10 (95% CI 2.7-4.7) and pain interference 3.5/10 (95% CI 2.5-4.5). CONCLUSIONS This meta-analysis provides the first reliable pain prevalence estimate in a large international sample of adults with CP. The high prevalence of pain, 70%, suggests that adults with CP should be routinely screened for pain and treated accordingly. The range of measurement instruments used by the included studies emphasizes using common outcome measures specific to pain internationally.
Collapse
Affiliation(s)
- Wilma M A van der Slot
- Rijndam Rehabilitation and Department of Rehabilitation Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
| | - Joyce L Benner
- Department of Rehabilitation Medicine, Erasmus University Medical Center and Rijndam Rehabilitation, Rotterdam, The Netherlands
| | - Laura Brunton
- School of Physical Therapy, Western University, London, Ontario, Canada
| | - Joyce M Engel
- Department of Occupational Science and Technology, University of Wisconsin-Milwaukee, Milwaukee, Wi, USA
| | - Philippe Gallien
- Breizh Paralysie Cérébrale Health Network, Pôle MPR Saint-Hélier, Rennes, France
| | - Sander R Hilberink
- Department of Rehabilitation Medicine, Erasmus University Medical Center and Research Center Innovations in Care, Rotterdam University of Applied Sciences, Rotterdam, The Netherlands
| | - Grethe Månum
- Department of Research, Sunnaas Rehabilitation Hospital and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Prue Morgan
- Department of Physiotherapy, Monash University, Frankston, Victoria, Australia
| | - Arve Opheim
- Department of Research, Sunnaas Rehabilitation Hospital, Nesoddtangen, Norway; Department of Research and Development, Habilitation & Health, Region Västra Götaland and Department of Rehabilitation Medicine, Sahlgrenska Academy, University of Gothenburg, Region Västra Götaland, Gothenburg, Sweden
| | - Inmaculada Riquelme
- Department of Nursing and Physiotherapy, University Institute of Health Sciences, University of the Balearic Islands, Palma de Mallorca, Mallorca, Spain
| | - Elisabet Rodby-Bousquet
- Center for Clinical Research, Uppsala University, Region Västmanland, Västerås and Department of Clinical Sciences, Orthopaedics, Lund University, Lund, Sweden
| | - Tülay Tarsuslu Şimşek
- School of Physical Therapy and Rehabilitation, Dokuz Eylül University, İzmir, Turkey
| | - Deborah E Thorpe
- Division of Physical Therapy, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Rita J G van den Berg-Emons
- Department of Rehabilitation Medicine, Erasmus University Medical Center and Rijndam Rehabilitation, Rotterdam, The Netherlands
| | - Laura K Vogtle
- Department of Occupational Therapy, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Grigorios Papageorgiou
- Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Marij E Roebroeck
- Department of Rehabilitation Medicine, Erasmus University Medical Center and Rijndam Rehabilitation, Rotterdam, The Netherlands
| |
Collapse
|
16
|
Peyronnet B, Hascoet J, Freton L, Khene Z, Graffeille V, Alimit Q, El-Akri M, Kerdraon J, Bonan I, Leblong E, Gallien P, Plassat R, Petrilli S, Durufle A, Mathieu R, Bensalah K, Verhoest G, Manunta A. Cystectomie et dérivation cutanée non continence de type Bricker pour vessie neurologique: comparaison des voies ouverte, laparoscopie et robot-assistée. Prog Urol 2019. [DOI: 10.1016/j.purol.2019.08.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
17
|
Maillart E, Labauge P, Cohen M, Maarouf A, Vukusic S, Donzé C, Gallien P, De Sèze J, Bourre B, Moreau T, Louapre C, Mayran P, Bieuvelet S, Vallée M, Bertillot F, Klaeylé L, Argoud AL, Zinaï S, Tourbah A. MSCopilot, a new multiple sclerosis self-assessment digital solution: results of a comparative study versus standard tests. Eur J Neurol 2019; 27:429-436. [PMID: 31538396 DOI: 10.1111/ene.14091] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2019] [Revised: 07/24/2019] [Accepted: 09/09/2019] [Indexed: 01/09/2023]
Abstract
BACKGROUND AND PURPOSE Assessing patients' disability in multiple sclerosis (MS) requires time-consuming batteries of hospital tests. MSCopilot is a software medical device for the self-assessment of patients with MS (PwMS), combining four tests: walking, dexterity, cognition and low contrast vision. The objective was to validate MSCopilot versus the Multiple Sclerosis Functional Composite (MSFC). METHODS This multicentre, open-label, randomized, controlled, crossover study enrolled 141 PwMS and 76 healthy controls (HCs). All participants performed MSCopilot and MSFC tests at day 0. To assess reproducibility, 46 PwMS performed the same tests at day 30 ± 3. The primary end-point was the validation of MSCopilot versus MSFC for the identification of PwMS against HCs, quantified using the area under the curve (AUC). The main secondary end-point was the correlation of MSCopilot z-scores with MSFC z-scores. RESULTS In all, 116 PwMS and 69 HCs were analysed. The primary end-point was achieved: MSCopilot performance was non-inferior to that of MSFC (AUC 0.92 and 0.89 respectively; P = 0.3). MSCopilot and MSFC discriminated PwMS and HCs with 81% and 76% sensitivity and 82% and 88% specificity respectively. Digital and standard test scores were highly correlated (r = 0.81; P < 0.001). The test-retest study demonstrated the good reproducibility of MSCopilot. CONCLUSION This study confirms the reliability of MSCopilot and its usability in clinical practice for the monitoring of MS-related disability.
Collapse
Affiliation(s)
- E Maillart
- Department of Neurology, Pitié Salpêtrière Hospital, Paris, France
| | - P Labauge
- Department of Neurology, Montpellier University Hospital, Montpellier, France
| | - M Cohen
- Department of Neurology, Nice University Hospital, Nice, France
| | - A Maarouf
- CNRS, CRMBM, APHM, Aix-Marseille University, Marseille, France.,Pole de Neurosciences Cliniques, Marseille, France
| | - S Vukusic
- Department of Neurology, Hospices Civils de Lyon, Bron, France.,INSERM 1028 et CNRS UMR 5292, University Lyon 1, Lyon, France
| | - C Donzé
- Department of Physical and Rehabilitation Medicine, Groupe Hospitalier de l'Institut Catholique de Lille, Lille, France
| | - P Gallien
- Physical Rehabilitation Medicine, Pole Saint Helier, Rennes, France
| | - J De Sèze
- Department of Neurology, Hôpital Civil, Strasbourg University, Strasbourg, France
| | - B Bourre
- Department of Neurology, Rouen University Hospital, Rouen, France
| | - T Moreau
- Department of Neurology, Dijon University Hospital, Dijon, France
| | - C Louapre
- Department of Neurology, Pitié Salpêtrière Hospital, Paris, France
| | | | - S Bieuvelet
- Ad Scientiam, Brain and Spine Institute (ICM), Pitié Salpêtrière Hospital, Paris, France
| | - M Vallée
- Ad Scientiam, Brain and Spine Institute (ICM), Pitié Salpêtrière Hospital, Paris, France
| | - F Bertillot
- Ad Scientiam, Brain and Spine Institute (ICM), Pitié Salpêtrière Hospital, Paris, France
| | - L Klaeylé
- Ad Scientiam, Brain and Spine Institute (ICM), Pitié Salpêtrière Hospital, Paris, France
| | - A-L Argoud
- Ad Scientiam, Brain and Spine Institute (ICM), Pitié Salpêtrière Hospital, Paris, France
| | - S Zinaï
- Ad Scientiam, Brain and Spine Institute (ICM), Pitié Salpêtrière Hospital, Paris, France
| | - A Tourbah
- Department of Neurology, Reims University Hospital, URCA, Reims, France.,LPN EA, 2027 Paris 8 University, Saint-Denis, France.,Service de Neurologie, Hôpitaux universitaires paris-Ile-de-France Ouest, APHP, Université Versailles-Saint Quentin en Yvelines, Paris Saclay, France
| |
Collapse
|
18
|
Esquenazi A, Fanning K, Zuzek A, Francisco G, Bandari D, Elmore M, Jensky N, Feng W(W, Wittenberg GF, Gallien P, Baricich A. Clinical Characteristics That Impact OnabotulinumtoxinA Treatment Adherence in Spasticity Patients From ASPIRE. Arch Phys Med Rehabil 2019. [DOI: 10.1016/j.apmr.2019.08.138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
19
|
Robineau S, Nicolas B, Mathieu L, Duruflé A, Leblong E, Fraudet B, Gélis A, Gallien P. Assessing the impact of a patient education programme on pressure ulcer prevention in patients with spinal cord injuries. J Tissue Viability 2019; 28:167-172. [PMID: 31288977 DOI: 10.1016/j.jtv.2019.06.001] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2019] [Revised: 06/02/2019] [Accepted: 06/05/2019] [Indexed: 10/26/2022]
Abstract
OBJECTIVES There is currently a low level of evidence for the impact of patient education on the management of patients with chronic neurological disease at risk of developing pressure ulcers. The objective of this study was to assess the impact of a patient education programme on pressure ulcer prevention in patients with chronic spinal cord injuries. MATERIALS AND METHODS This study included adult patients with any spinal cord injury, regardless of the cause. Participants attended 2 group workshops focusing on pressure ulcer prevention. Various clinical data were gathered during an initial individual interview and at 3, 6 and 12 months, along with rating scale values from the Hospital Anxiety and Depression Scale, Rosenberg self-esteem scale, Schwarzer self-efficacy scale, a quality of life scale (SF-36) and the revised Skin Management Needs Assessment Checklist (Revised SMnac), which was used as the primary endpoint. RESULTS Twenty patients were included in the study. The mean patient age was 52 years (SD: 9,8). Sixteen patients had traumatic spinal cord injuries, with a median injury duration of 234 months (IQR: 123-407). Seventy-five percent had had a pressure ulcer in the twelve months prior to the study. Patient education was shown to have a significant impact on skin management ability, with a highly significant increase in the overall revised SMnac score at 3 months. These results were stable over time, from 6 to 12 months. Six patients developed a pressure ulcer during the study (30%). CONCLUSION This study supports the hypothesis that a therapeutic educational program conducted at the chronic phase in spinal cord injured individuals has an impact.
Collapse
Affiliation(s)
- S Robineau
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France.
| | - B Nicolas
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| | - L Mathieu
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| | - A Duruflé
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| | - E Leblong
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| | - B Fraudet
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| | - A Gélis
- Centre Mutualiste Neurologique PROPARA, 263 Rue Du Caducée, 34090, Montpellier, France
| | - P Gallien
- Pôle MPR Saint Hélier, 54 Rue Saint Hélier, CS 74330, 35043, Rennes Cedex, France
| |
Collapse
|
20
|
Lebrun C, Vukusic S, Abadie V, Achour C, Ader F, Alchaar H, Alkhedr A, Andreux F, Androdias G, Arjmand R, Audoin B, Audry D, Aufauvre D, Autreaux C, Ayrignac X, Bailbe M, Benazet M, Bensa C, Bensmail D, Berger E, Bernady P, Bertagna Y, Biotti D, Blanchard-Dauphin A, Bonenfant J, Bonnan M, Bonnemain B, Borgel F, Botelho-Nevers E, Boucly S, Bourre B, Boutière C, Branger P, Brassat D, Bresch S, Breuil V, Brochet B, Brugeilles H, Bugnon P, Cabre P, Camdessanché JP, Carra-Dalière C, Casez O, Chamouard JM, Chassande B, Chataignier P, Chbicheb M, Chenet A, Ciron J, Clavelou P, Cohen M, Colamarino R, Collongues N, Coman I, Corail PR, Courtois S, Coustans M, Creange A, Creisson E, Daluzeau N, Davenas C, De Seze J, Debouverie M, Depaz R, Derache N, Divio L, Douay X, Dulau C, Durand-Dubief F, Edan G, Elias Z, Fagniez O, Faucher M, Faucheux JM, Fournier M, Gagneux-Brunon A, Gaida P, Galli P, Gallien P, Gaudelus J, Gault D, Gayou A, Genevray M, Gentil A, Gere J, Gignoux L, Giroux M, Givron P, Gout O, Grimaud J, Guennoc AM, Hadhoum N, Hautecoeur P, Heinzlef O, Jaeger M, Jeannin S, Kremer L, Kwiatkowski A, Labauge P, Labeyrie C, Lachaud S, Laffont I, Lanctin-Garcia C, Lannoy J, Lanotte L, Laplaud D, Latombe D, Lauxerois M, Le Page E, Lebrun-Frenay C, Lejeune P, Lejoyeux P, Lemonnier B, Leray E, Loche CM, Louapre C, Lubetzki C, Maarouf A, Mada B, Magy L, Maillart E, Manchon E, Marignier R, Marque P, Mathey G, Maurousset A, Mekies C, Merienne M, Michel L, Milor AM, Moisset X, Montcuquet A, Moreau T, Morel N, Moussa M, Naudillon JP, Normand M, Olive P, Ouallet JC, Outteryck O, Pacault C, Papeix C, Patry I, Peaureaux D, Pelletier J, Pichon B, Pittion S, Planque E, Pouget MC, Pourcher V, Radot C, Robert I, Rocher F, Ruet A, Ruet A, Saint-Val C, Salle JY, Salmon A, Sartori E, Schaeffer S, Stankhof B, Taithe F, Thouvenot E, Tizon C, Tourbah A, Tourniaire P, Vaillant M, Vermersch P, Vidil S, Wahab A, Warter MH, Wiertlewski S, Wiplosz B, Wittwer B, Zaenker C, Zephir H. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society. Rev Neurol (Paris) 2019; 175:341-357. [DOI: 10.1016/j.neurol.2019.04.001] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2019] [Revised: 03/31/2019] [Accepted: 04/11/2019] [Indexed: 10/26/2022]
|
21
|
Wissel J, Hoonhorst M, Müngersdorf M, Gallien P, Meier N, Hefter H, Koch M, Raymond R, Fheodoroff K. First results from the early bird study, a prospective, noninterventional study to assess effectiveness of abobotulinumtoxinA (Dysport®) in poststroke upper limb spasticity in relation to timing of treatment. Toxicon 2018. [DOI: 10.1016/j.toxicon.2018.11.277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
22
|
Roquet M, Garlantezec R, Remy-Neris O, Sacaze E, Gallien P, Ropars J, Houx L, Pons C, Brochard S. From childhood to adulthood: health care use in individuals with cerebral palsy. Dev Med Child Neurol 2018; 60:1271-1277. [PMID: 30171608 DOI: 10.1111/dmcn.14003] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/12/2018] [Indexed: 11/29/2022]
Abstract
AIM To analyse the health care usage of individuals with cerebral palsy (CP) as a function of age and ambulatory status. METHOD In total, 970 self-administered questionnaires relating to health care usage were sent, via a clinical network of professionals and institutions, to children and adults with CP in Brittany, France. Frequency of use of different aspects of health care were analysed as a function of age and ambulatory status. Multivariate logistic regression evaluated differences in the frequency of each health care type with age; the transition from childhood to adulthood was specifically analysed. RESULTS The response rate was 53% (282 adults, 230 children). Use of medication (particularly psychotropic and analgesic) increased with age, while physical-types of health care (rehabilitation, physical medicine and rehabilitation follow-up, and equipment) decreased with age, independently of ambulatory status. Use of other treatments, such as botulinum toxin injections, was not influenced by age. The provision of rehabilitation was particularly affected by the period of transition. INTERPRETATION Although health care needs change naturally in adulthood, the large decrease in usage of specific types of rehabilitation after the transition to adulthood suggested individuals had difficulty accessing this type of health care after childhood. These results provide objectives for the development of patient-centred, transitional consultations, and longitudinal studies. WHAT THIS PAPER ADDS Use of medication, particularly psychotropic and analgesic drugs, increased with age in individuals with cerebral palsy. Use of orthoses, physical medicine and rehabilitation physician follow-up, and rehabilitation decreased with age. Transition from childhood to adulthood involved significant changes in health care usage.
Collapse
Affiliation(s)
- Marion Roquet
- Médecine Physique et de Réadaptation, CHRU Brest, Brest, France.,Fondation Ildys, Brest, France
| | | | - Olivier Remy-Neris
- Médecine Physique et de Réadaptation, CHRU Brest, Brest, France.,Université de Bretagne Occidentale, Brest, France.,Laboratoire de Traitement de l'Information Médicale, INSERM, UMR 1101, Brest, France
| | | | - Philippe Gallien
- Médecine Physique et de Réadaptation, CMPR Notre Dame De Lourde, Rennes, France
| | - Juliette Ropars
- Laboratoire de Traitement de l'Information Médicale, INSERM, UMR 1101, Brest, France.,Service de Pédiatrie, CHRU Brest, Brest, France
| | - Laetitia Houx
- Médecine Physique et de Réadaptation, CHRU Brest, Brest, France.,Fondation Ildys, Brest, France.,Laboratoire de Traitement de l'Information Médicale, INSERM, UMR 1101, Brest, France
| | - Christelle Pons
- Médecine Physique et de Réadaptation, CHRU Brest, Brest, France.,Fondation Ildys, Brest, France.,Laboratoire de Traitement de l'Information Médicale, INSERM, UMR 1101, Brest, France
| | - Sylvain Brochard
- Médecine Physique et de Réadaptation, CHRU Brest, Brest, France.,Fondation Ildys, Brest, France.,Université de Bretagne Occidentale, Brest, France.,Laboratoire de Traitement de l'Information Médicale, INSERM, UMR 1101, Brest, France
| |
Collapse
|
23
|
Bonnyaud C, Gallien P, Decavel P, Marque P, Aymard C, Pellas F, Isner ME, Boyer FC, Muller F, Daviet JC, Dehail P, Perrouin-Verbe B, Bayle N, Coudeyre E, Perennou D, Laffont I, Ropers J, Domingo-Saidji NY, Bensmail D, Roche N. Effects of a 6-month self-rehabilitation programme in addition to botulinum toxin injections and conventional physiotherapy on limitations of patients with spastic hemiparesis following stroke (ADJU-TOX): protocol study for a randomised controlled, investigator blinded study. BMJ Open 2018; 8:e020915. [PMID: 30166290 PMCID: PMC6119443 DOI: 10.1136/bmjopen-2017-020915] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
INTRODUCTION Home-based self-rehabilitation programmes combined with botulinum toxin injections (BTIs) appear to be a relevant approach to increase the recommended intensive rehabilitation of patients with spasticity following a stroke. The literature highlights a lack of evidence of beneficial effects of this adjuvant therapy to reduce limitations of patients with stroke. The aim of this study is to assess the effects of a 6-month self-rehabilitation programme in adjunction to BTI, in comparison with BTI alone, to reduce limitations of patients with spasticity following a stroke. METHODS AND ANALYSIS 220 chronic patients will participate to this multicentre, prospective, randomised, controlled, assessor blinded study. All patients will benefit from two successive BTI (3 months apart), and patients randomised in the self-rehabilitation group will perform in adjunction 6 months of self-rehabilitation at home. All patients continue their conventional physiotherapy. The main outcome is the primary treatment goal (PTG), which will be determined jointly by the patient and the medical doctor using Goal Attainment Scaling. Impairments and functions, quality of life, mood and fatigue will be assessed. Botulinum toxin will be injected into the relevant muscles according to the PTG. Patients in the self-rehab group will be taught the self-rehabilitation programme involving respectively 10 min of stretching, 10 min of strengthening and 10 min of task-oriented exercises, corresponding to their PTG. Compliance to the self-rehabilitation programme will be monitored. ETHICS AND DISSEMINATION Patients will sign written informed consent. Ethical approval was obtained from ethics committee. The results will be disseminated in a peer-reviewed journal and presented at international congresses. The results will also be disseminated to patients. TRIAL REGISTRATION NUMBER NCT02944929.
Collapse
Affiliation(s)
- Celine Bonnyaud
- Service de Physiologie et d’exploration Fonctionnelle, Hôpital Raymond Poincaré APHP, Garches, Université Versailles Saint Quentin en Yvelines, Garches, France
| | - Philippe Gallien
- Service de Médecine Physique et de Réadaptation, Pole Saint-Helier, Rennes, Bretagne, France
| | - Pierre Decavel
- Service de Médecine Physique et de Réadaptation, Hôpital Jean-Minjoz, Besançon, France
| | - Philippe Marque
- Service de Médecine Physique et de Réadaptation, Hôpital Rangueil, Toulouse, France
| | - Claire Aymard
- Service de Médecine Physique et de Réadaptation, Fondation Hospitaliere Sainte-Marie, Paris, France
| | - Frédéric Pellas
- Service Rééducation Post Réanimation, Unité Cérébro-Lésés, Hopital Carémeau, Nimes, France
| | - Marie-Eve Isner
- Service de Médecine Physique et de Réadaptation, Institut Réadaptation Clémenceau, Strasbourg, France
| | | | - François Muller
- Service de Médecine Physique et de Réadaptation, Clinique Les Embruns, Bidart, France
| | | | - Patrick Dehail
- Service de Médecine Physique et de Réadaptation, Hôpital Pellegrin, Bordeaux, France
| | | | - Nicolas Bayle
- Service de Médecine Physique et de Réadaptation, Albert Chenevier, Hôpital Henri Mondor, Créteil, France
| | - Emmanuel Coudeyre
- Service de Médecine Physique et de Réadaptation, Hôpital Nord, Clermont-Ferrand, France
| | - Dominic Perennou
- Service de Médecine Physique et de Réadaptation, Neurologie, Centre Hospitalier Universitaire, Grenoble, France
| | - Isabelle Laffont
- Service de Médecine Physique et de Réadaptation, Centre Hospitalier Regional Universitaire de Montpellier, Montpellier, France
| | - Jacques Ropers
- Unité de Recherche Clinique, Paris Île-de-France Ouest (URCPO), Hôpital Raymond Poincaré, APHP, Garches, France
| | | | - Djamel Bensmail
- Service de Physiologie et d’exploration Fonctionnelle, Hôpital Raymond Poincaré APHP, Garches, Université Versailles Saint Quentin en Yvelines, Garches, France
| | - Nicolas Roche
- Service de Physiologie et d’exploration Fonctionnelle, Hôpital Raymond Poincaré APHP, Garches, Université Versailles Saint Quentin en Yvelines, Garches, France
| |
Collapse
|
24
|
Gallien P, Leroux R, Nicolas B, Coignard P, Durufle A, Bouton M, Chapelain F, Colin A. Impact of cognitive disorders on schooling and socio-professional integrations in adults with cerebral palsy. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
25
|
Duruflé, Mathieu L, Robineau S, Nicolas B, Leblong E, Fraudet B, Gelis A, Gallien P. Evaluation of the impact of a therapeutic educational program concerning the prevention of risk of pressure ulcers for persons with a spinal cord lesion. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.894] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
26
|
Duruflé, Aubry J, Bordas M, Gallien P, Le Meur C, Nicolas B. Alternative to supply of health services in physical medicine and rehabilitation: From mobile team to home hospitalization. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.1181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
27
|
Gallien P, Colin A, Nicolas B, Durufle A, Brion A, Achille-Fauveau S. Access to dental care for people with disabilities in Britanny. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
28
|
Fraudet B, Leblong E, Gallien P, Nicolas B, Dandois M. BYMTOX: An observational study to consider the association of botulinum toxin and self-management program by serious game for post-stroke patients at the chronic phase. Ann Phys Rehabil Med 2017. [DOI: 10.1016/j.rehab.2017.07.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
29
|
Fraudet B, Vogt P, Leblong E, Denis G, Gallien P, Nicolas B, Louis C, De Saint Victor E, Briand A. Satisfaction of French rehabilitation nurses about practice: Observational study. Ann Phys Rehabil Med 2017. [DOI: 10.1016/j.rehab.2017.07.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
30
|
Gallien P, Nicolas B, Devigne L, Pasteau F, Lepape L, Babel M, Colin A, Achille S, Fraudet B. Virtual reality simulator for speeding up research on assisted power wheelchair navigation. Ann Phys Rehabil Med 2017. [DOI: 10.1016/j.rehab.2017.07.234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
31
|
Leblong E, Fraudet B, Quere T, Palomera P, Ceze E, Jegat E, Poulain H, Nicolas B, Gallien P. Prospective study of specific rehabilitation in Parkinson's disease: Effectiveness on gait and balance of a group ambulatory hospitalization in extrapyramidal disorders. Ann Phys Rehabil Med 2017. [DOI: 10.1016/j.rehab.2017.07.076] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
32
|
Gallien P, Rat D, Robineau S, Houedakor J, Leblong E, Benoit N, Durufle A, Fraudet B. Hyperbaric trauma of an intrathecal baclofen pump secondary to scuba diving: About one case. Ann Phys Rehabil Med 2017. [DOI: 10.1016/j.rehab.2017.07.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
33
|
Devigne L, Babel M, Nouviale F, Narayanan VK, Pasteau F, Gallien P. Design of an immersive simulator for assisted power wheelchair driving. IEEE Int Conf Rehabil Robot 2017; 2017:995-1000. [PMID: 28813951 DOI: 10.1109/icorr.2017.8009379] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Driving a power wheelchair is a difficult and complex visual-cognitive task. As a result, some people with visual and/or cognitive disabilities cannot access the benefits of a power wheelchair because their impairments prevent them from driving safely. In order to improve their access to mobility, we have previously designed a semi-autonomous assistive wheelchair system which progressively corrects the trajectory as the user manually drives the wheelchair and smoothly avoids obstacles. Developing and testing such systems for wheelchair driving assistance requires a significant amount of material resources and clinician time. With Virtual Reality technology, prototypes can be developed and tested in a risk-free and highly flexible Virtual Environment before equipping and testing a physical prototype. Additionally, users can "virtually" test and train more easily during the development process. In this paper, we introduce a power wheelchair driving simulator allowing the user to navigate with a standard wheelchair in an immersive 3D Virtual Environment. The simulation framework is designed to be flexible so that we can use different control inputs. In order to validate the framework, we first performed tests on the simulator with able-bodied participants during which the user's Quality of Experience (QoE) was assessed through a set of questionnaires. Results show that the simulator is a promising tool for future works as it generates a good sense of presence and requires rather low cognitive effort from users.
Collapse
|
34
|
Guinet-Lacoste A, Kerdraon J, Rousseau A, Gallien P, Previnaire JG, Perrouin-Verbe B, Amarenco G. Intermittent catheterization acceptance test (I-CAT): A tool to evaluate the global acceptance to practice clean intermittent self-catheterization. Neurourol Urodyn 2017; 36:1846-1854. [DOI: 10.1002/nau.23195] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2016] [Accepted: 11/25/2016] [Indexed: 11/09/2022]
Affiliation(s)
- Amandine Guinet-Lacoste
- Sorbonne Universités; UPMC Univ Paris 06, GRC 01, GREEN; Group of Clinical Research in Neuro-Urology; Paris France
- AP-HP, Hôpital Tenon; Neuro-urologie et Explorations Périnéales; Paris France
| | | | - Alexandra Rousseau
- Department of Clinical Pharmacology and Unité de Recherche Clinique (URCEST); AP-HP, Hôpital Saint Antoine; Paris France
| | | | | | | | - Gérard Amarenco
- Sorbonne Universités; UPMC Univ Paris 06, GRC 01, GREEN; Group of Clinical Research in Neuro-Urology; Paris France
- AP-HP, Hôpital Tenon; Neuro-urologie et Explorations Périnéales; Paris France
| |
Collapse
|
35
|
Leblong E, Fraudet B, Petrilli S, Berthier T, Autret K, Gambert S, Anne C, Nicolas B, Gallien P. Therapeutic benefit of botulinum toxin A for spasticity of the triceps surae in patients with multiple sclerosis: an observational study on gait spatiotemporal parameters. Toxicon 2016. [DOI: 10.1016/j.toxicon.2016.11.149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
36
|
Gallien P, Nicolas B, Durufle A, Le-Meur C, Leblong E, Chochina L, Robineau S, Petrilli S, Houedakor J. Constipation prevalence in multiple sclerosis about a cohort of 81 patients. Ann Phys Rehabil Med 2016. [DOI: 10.1016/j.rehab.2016.07.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
37
|
Gallien P, Nicolas B, Emilie L, Petrilli S, Robineau S, Durufle A, Autret K, Berthier T, Chochina L, Fraudet B, Pfeiffer C. Therapeutic benefit of botulinum toxin A for the spasticity of the triceps surae in patients with multiple sclerosis: An observational study. Ann Phys Rehabil Med 2016. [DOI: 10.1016/j.rehab.2016.07.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
38
|
Pons C, Brochard S, Gallien P, Nicolas B, Duruflé A, Roquet M, Rémy-Néris O, Garlantezec R. Medication, rehabilitation and health care consumption in adults with cerebral palsy: a population based study. Clin Rehabil 2016; 31:957-965. [DOI: 10.1177/0269215516663286] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Objective: To evaluate medication, rehabilitation and healthcare consumption in adults with CP as a function of Gross Motor Function Classification System (GMFCS) level. Design: Questionnaire-based cross-sectional study. Setting: Brittany, a French county. Subjects: Adults with cerebral palsy. Interventions: Questionnaires relating to drugs, orthotic devices, mobility aids, rehabilitation and medical input were sent to 435 members of a unique regional French network dedicated to adults with cerebral palsy. The questionnaire was completed by the participant or a helper if necessary. Results: Of the 282 responders, 7.8% had a GMFCS level of I, 14.2% II, 17.7% III, 29.1% IV and 31.2% V. Participants consumed a large amount of healthcare. Almost three-quarters took orally administered drugs, of which antispastic and antiepileptic drugs were among the most frequent. Nearly all patients had at least one type of rehabilitation, 87.2% had physiotherapy, 78% used at least one mobility aid and 69.5% used at least one orthotic device. The frequency of numerous inputs increased with GMFCS level. Specificities were found for each GMFCS level, e.g. participants with GMFCS level IV and V had a high level of medical input and a greater use of trunk-supporting devices, antireflux and laxative. Profiles could be established based on GMFCS levels. Conclusions: Adults with cerebral palsy use a large amount of drugs, mobility aids, orthotic devices, rehabilitation and medical input. Healthcare is targeted at cerebral palsy-related issues. GMFCS is a determinant of healthcare consumption and thus a useful tool for clinical practice to target care appropriately.
Collapse
Affiliation(s)
- Christelle Pons
- Physical medicine and rehabilitation, CHRU Brest, France
- Fondation ILDYS, Brest, France
- Université de Bretagne Occidentale, Brest, France
- Laboratoire de Traitement de l’Information Médicale, Brest, France
| | - Sylvain Brochard
- Physical medicine and rehabilitation, CHRU Brest, France
- Fondation ILDYS, Brest, France
- Université de Bretagne Occidentale, Brest, France
- Laboratoire de Traitement de l’Information Médicale, Brest, France
| | - Philippe Gallien
- Physical medicine and rehabilitation, Pôle MPR Saint Hélier, Rennes, France
| | - Benoit Nicolas
- Physical medicine and rehabilitation, Pôle MPR Saint Hélier, Rennes, France
| | - Aurélie Duruflé
- Physical medicine and rehabilitation, Pôle MPR Saint Hélier, Rennes, France
| | - Marion Roquet
- Physical medicine and rehabilitation, CHRU Brest, France
| | - Olivier Rémy-Néris
- Physical medicine and rehabilitation, CHRU Brest, France
- Université de Bretagne Occidentale, Brest, France
- Laboratoire de Traitement de l’Information Médicale, Brest, France
| | - Ronan Garlantezec
- Public Health departement, CHU Rennes, University Rennes 1 Rennes, France
| |
Collapse
|
39
|
Babel M, Pasteau F, Fraudet B, Achille S, Colin A, Nicolas B, Durufle A, Le Pape L, Gallien P. Assessment of a navigation assistance system for power wheelchair. Ann Phys Rehabil Med 2015. [DOI: 10.1016/j.rehab.2015.07.241] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
40
|
Boggs D, Urseau I, Gallien P, Lippolis G. Analysing the sustainability of the physical rehabilitation sector in seven fragile countries through multi-stakeholder involvement using a participatory consensus tool. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.1725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
41
|
Roquet M, Garlantezec R, Gallien P, Pons C, Houx L, Rémy-Néris O, Brochard S. Impact of age and especially the transition on the rehabilitative and medical care in individuals with cerebral palsy in Britanny. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
42
|
Gallien P, Nicolas B, Durufle A, Robineau S, Petrilli S, Autret K, Houedakor J, Le Meur C. Physical training and muscle strengthening in multiple sclerosis. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
43
|
Roquet M, Garlantezec R, Gallien P, Pons C, Houx L, Rémy-Néris O, Brochard S. Effet de l’âge et de la transition enfant-adulte sur la prise en charge médicale et rééducative des personnes avec paralysie cérébrale en Bretagne. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
44
|
Nicolas B, Robineau-Beneux S, Lebot M, Durufle A, Petrilli S, Gallien P. Prevalence of pressure sores in EPHAD in Britanny. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
45
|
Duruflé A, Gallien P, Nicolas B, Colin A. Analysis of the medical causes of death in cerebral palsy. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
46
|
Allaire C, Brau S, Dantec N, Gallien P. L’épilepsie chez le polyhandicapé : stratégies de prise en charge en institution. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
47
|
Nicolas B, Colin A, Durufle A, Achille S, Dauvergne F, Lepape L, Gallien P. BreizhPC network: First health network dedicated to adults with cerebral palsy. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
48
|
Coudeyre E, Givron P, Demaille-Wlodyka S, Gallien P. Self care programs and multiple sclerosis: A systematic literature review. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
49
|
Robineau-Beneux S, Durufle A, Nicolas B, Chopin A, Lebot M, Petrilli S, Gallien P. Management of pressure sore at home, back from a survey about 2013 liberal nurses in Lille et Vilaine. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Leroux R, Gruson M, Durufle A, Nicolas B, Coignard P, Lassalle A, Colin A, Gallien P, Groupe P, Chapelain F. Cognitive disorders in adults with cerebral palsy. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.1238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|